Reaction
Renal-Limited Thrombotic Microangiopathy reporting signals
As of the last recalculation, Renal-Limited Thrombotic Microangiopathy appears in 223 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is SIROLIMUS (PRR 127.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sirolimus | 17 | 127.4 | 127.6 |
| Mycophenilic Acid | 25 | 126.7 | 126.8 |
| Basiliximab | 13 | 109.5 | 109.6 |
| Mycophenolic Acid | 27 | 89.4 | 89.5 |
| Gemcitabine Hydrochloride | 30 | 60.8 | 60.9 |
| Thiotepa | 6 | 60.2 | 60.3 |
| Bleomycin Sulfate | 6 | 55.7 | 55.7 |
| Gemcitabine | 20 | 52.0 | 52.0 |
| Temozolomide | 9 | 41.5 | 41.5 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 4 | 28.8 | 28.8 |